Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1977;4(Suppl 2):135S–141S. doi: 10.1111/j.1365-2125.1977.tb05740.x

Human pharmacology of antidepressives

M Lader
PMCID: PMC1429092  PMID: 334215

Abstract

1 As both the tricyclic antidepressives and the monoamine oxidase (MAO) inhibitors were discovered accidently, their pharmacology has been established on an empirical post hoc basis only. There are no convincing models of depression in the normal human. The classification of depression remains controversial; also the relationship between clinical depression, depressive reactions and pessimistic personality traits is unresolved. Antidepressive effects are demonstrable in lugubrious normals.

2 Pharmacokinetic and drug interaction data are important in the usage of a drug and are available from studies in normals. Secondary psychotropic effects such as sedation can be readily studied both in normals and in patients. The antidepressives produce characteristic changes in the electroencephalogram (EEG). Unwanted effects are often related to autonomic actions which can be readily quantified, salivation being most extensively studied. Psychological impairment is dose related in normals but lessens over a course of treatment in patients.

3 Biochemical measures have been little explored despite their obvious relevance. MAO activity in platelets is diminished by MAO inhibitors. Tricyclic drugs inhibit the uptake of amines into neurones and platelets, and this inhibition can be assessed in various ways.

4 Drug experiments in normal subjects provide data which complement, amplify and elucidate observations in patients without ever substituting for them.

Full text

PDF
135S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexanderson B., Evans D. A., Sjöqvist F. Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br Med J. 1969 Dec 27;4(5686):764–768. doi: 10.1136/bmj.4.5686.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alexanderson B. Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data. Eur J Clin Pharmacol. 1972 Mar;4(2):82–91. doi: 10.1007/BF00562502. [DOI] [PubMed] [Google Scholar]
  3. Asberg M., Bertilsson L., Tuck D., Cronholm B., Sjöqvist F. Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline. Clin Pharmacol Ther. 1973 Mar-Apr;14(2):277–286. doi: 10.1002/cpt1973142277. [DOI] [PubMed] [Google Scholar]
  4. Blackwell B., Lipkin J. O., Meyer J. H., Kuzma R., Boulter W. V. Dose responses and relationships between anticholinergic activity and mood with tricyclic antidepressants. Psychopharmacologia. 1972;25(3):205–217. doi: 10.1007/BF00422502. [DOI] [PubMed] [Google Scholar]
  5. DIMASCIO A., HENINGER G., KLERMAN G. L. PSYCHOPHARMACOLOGY OF IMIPRAMINE AND DESIPRAMINE: A COMPARATIVE STUDY OF THEIR EFFECTS IN NORMAL MALES. Psychopharmacologia. 1964 Apr 3;5:361–371. doi: 10.1007/BF00441447. [DOI] [PubMed] [Google Scholar]
  6. Dimascio A., Meyer R. E., Stifler L. Effects of imipramine on individuals varying in level of depression. Am J Psychiatry. 1968 Feb;124(8 Suppl):55–58. doi: 10.1176/ajp.124.8S.55. [DOI] [PubMed] [Google Scholar]
  7. IDESTROEM C. M., CADENIUS B. IMIPRAMINE-DESMETHYLIMIPRAMINE. A PHARMACOLOGICAL STUDY ON HUMAN BEINGS. Psychopharmacologia. 1964 Jun 8;5:431–439. doi: 10.1007/BF02193480. [DOI] [PubMed] [Google Scholar]
  8. Karniol I. G., Dalton J., Lader M. Comparative psychotropic effects of trazodone, imipramine and diazepam in normal subjects. Curr Ther Res Clin Exp. 1976 Sep;20(3):337–348. [PubMed] [Google Scholar]
  9. Keeler M. H., Prange A. J., Jr, Reifler C. B. Effects of imipramine and thioridazine on set and attention. Dis Nerv Syst. 1966 Dec;27(12):798–802. [PubMed] [Google Scholar]
  10. Lauber H., Hartmann R., Hermann D. [The effects of tranquilizers and thymoleptic drugs on the human pupil]. Ger Med Mon. 1967 May;12(5):232–234. [PubMed] [Google Scholar]
  11. Lingjaerde O. Effect of doxepin on uptake and efflux of serotonin human blood patelets in vitro. Psychopharmacologia. 1976 May 28;47(2):183–186. doi: 10.1007/BF00735819. [DOI] [PubMed] [Google Scholar]
  12. Milner G., Landauer A. A. The effects of doxepin, alone and together with alcohol, in relation to driving safety. Med J Aust. 1973 Apr 28;1(17):837–841. [PubMed] [Google Scholar]
  13. Saletu B., Saletu M., Itil T. M. Effect of tricyclic antidepressants on the somatosensory evoked potential in man. Psychopharmacologia. 1973 Feb 27;29(1):1–12. doi: 10.1007/BF00421206. [DOI] [PubMed] [Google Scholar]
  14. Sneddon J. M. Blood platelets as a model for monoamine-containing neurones. Prog Neurobiol. 1973;1(2):151–198. doi: 10.1016/0301-0082(73)90019-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES